{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:39Z","timestamp":1790892639417,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cancergen.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T13:51:17Z","timestamp":1539179477000},"page":"197-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic\/myeloproliferative and myeloproliferative neoplasms"],"prefix":"10.1016","volume":"228-229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-5249","authenticated-orcid":false,"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennelle C.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Yenamandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Dixon-McIver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bryke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Huxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-9721","authenticated-orcid":false,"given":"Patrick A.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Raca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-0648","authenticated-orcid":false,"given":"Xinjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Jeffries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Quintero-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn L.","family":"Slovak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Anwar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2018.07.003_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0003","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0004","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.6004\/jnccn.2016.0169","article-title":"Myeloproliferative Neoplasms, Version 2.2017, NCCN clinical practice guidelines in oncology","volume":"14","author":"Mesa","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.6004\/jnccn.2017.0157","article-title":"NCCN guidelines insights: myeloproliferative neoplasms, Version 2.2018","volume":"15","author":"Mesa","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.6004\/jnccn.2017.0007","article-title":"Myelodysplastic syndromes, Version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Greenberg","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0008","first-page":"193","article-title":"The new NCCN guidelines for the management of myelofibrosis","volume":"15","author":"Mesa","year":"2017","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0009","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","volume":"122","author":"Malcovati","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3324\/haematol.2014.114660","article-title":"An international MDS\/MPN working group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic\/myeloproliferative neoplasms","volume":"100","author":"Mughal","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0011","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0012","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2007-05-092304","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD, and MDS-derived AML","volume":"111","author":"Gondek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cancergen.2017.07.010","article-title":"Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies","volume":"216-217","author":"Mukherjee","year":"2017","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0014","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2010-07-295857","article-title":"Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies","volume":"117","author":"Tiu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.22005","article-title":"Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category","volume":"52","author":"Huh","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0016","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/leu.2009.82","article-title":"Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics","volume":"23","author":"Heinrichs","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3324\/haematol.13024","article-title":"Frequent genomic abnormalities in acute myeloid leukemia\/myelodysplastic syndrome with normal karyotype","volume":"94","author":"Akagi","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0018","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/leu.2010.293","article-title":"Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance","volume":"25","author":"Thiel","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/gcc.21927","article-title":"From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype","volume":"51","author":"Merkerova","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.24227","article-title":"Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases","volume":"91","author":"Palomo","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0021","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/modpathol.2016.104","article-title":"Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance","volume":"29","author":"Evans","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0022","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2011-02-339747","article-title":"TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics","volume":"118","author":"Chou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0023","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0024","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.2011.08911.x","article-title":"TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele","volume":"156","author":"Bacher","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0025","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.exphem.2007.08.009","article-title":"Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes","volume":"35","author":"Gondek","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0026","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2007-11-122028","article-title":"High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival","volume":"112","author":"Starczynowski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0027","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.leukres.2009.08.023","article-title":"FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)","volume":"34","author":"Makishima","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8166-3-23","article-title":"Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic\/myeloproliferative syndromes","volume":"3","author":"Slovak","year":"2010","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0029","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/leu.2015.110","article-title":"High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)","volume":"29","author":"Mohamedali","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00277-016-2698-7","article-title":"The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China","volume":"95","author":"Hu","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0031","article-title":"Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome","author":"Yeung","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0032","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/leu.2015.257","article-title":"Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletions","volume":"30","author":"Volkert","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0033","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2011.36.1824","article-title":"Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited","volume":"30","author":"Jerez","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0034","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.12612","article-title":"Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and\/or -7\/del(7q)","volume":"12","author":"Zhang","year":"2015","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gcc.22112","article-title":"Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing","volume":"52","author":"Arenillas","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0036","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250\u202fK single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0037","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1200\/JCO.2009.22.6985","article-title":"Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome","volume":"27","author":"Mohamedali","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.leukres.2016.01.009","article-title":"Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes","volume":"42","author":"Svobodova","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0039","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ajh.22166","article-title":"Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm","volume":"86","author":"Rumi","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0041","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2009-10-201848","article-title":"Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies","volume":"115","author":"O'Keefe","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1755-8166-4-3","article-title":"Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"4","author":"Bajaj","year":"2011","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0043","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1371\/journal.pone.0001225","article-title":"SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS\/MPD-U and MPD","volume":"2","author":"Gondek","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0044","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1038\/bcj.2013.52","article-title":"Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine","volume":"3","author":"Cluzeau","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0045","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2007-03-079673","article-title":"Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes","volume":"110","author":"Mohamedali","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0046","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cancergen.2011.10.004","article-title":"Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes","volume":"204","author":"Kolquist","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0047","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1373\/clinchem.2014.227785","article-title":"Detection of clonal evolution in hematopoietic malignancies by combining comparative genomic hybridization and single nucleotide polymorphism arrays","volume":"60","author":"Hartmann","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0048","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.leukres.2015.06.011","article-title":"Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS","volume":"39","author":"Ganster","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0049","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00277-011-1195-2","article-title":"Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia","volume":"90","author":"Huh","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2009-03-210377","article-title":"SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations","volume":"115","author":"Nowak","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0051","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2010.65","article-title":"High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0052","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.20303","article-title":"Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high\u2010resolution array\u2010based comparative genomic hybridization","volume":"45","author":"Hosoya","year":"2006","journal-title":"Genes Chromos Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0053","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0054","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1755-8166-6-59","article-title":"Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease","volume":"6","author":"Singh","year":"2013","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/ijlh.12257","article-title":"Genomic aberrations of myeloproliferative and myelodysplastic\/myeloproliferative neoplasms in chronic phase and during disease progression","volume":"37","author":"Hahm","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0056","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2009-07-235119","article-title":"Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"115","author":"Thoennissen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0057","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","article-title":"Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression","volume":"118","author":"Klampfl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0058","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/leu.2010.148","article-title":"A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications","volume":"24","author":"Passamonti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0059","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.22257","article-title":"Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies","volume":"87","author":"Puda","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-8722-5-4","article-title":"Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide","volume":"5","author":"Sugimoto","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0061","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1309\/AJCPH27ZIZEJLORF","article-title":"Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities","volume":"134","author":"Vercauteren","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0062","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/gcc.22377","article-title":"The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations","volume":"55","author":"Stengel","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0063","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/leu.2010.304","article-title":"An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling","volume":"25","author":"Flach","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0064","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jclinpath-2016-204023","article-title":"Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome","volume":"70","author":"da Silva","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0065","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.2010.31.8576","article-title":"TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression","volume":"29","author":"Jadersten","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0066","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00277-014-2022-3","article-title":"Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide","volume":"93","author":"Gaballa","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0067","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.beha.2013.10.013","article-title":"Deletion 5q MDS: molecular and therapeutic implications","volume":"26","author":"Komrokji","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0068","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2014-06-582809","article-title":"TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0069","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/leu.2011.71","article-title":"Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias","volume":"25","author":"Itzykson","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13148-016-0237-y","article-title":"A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers","volume":"8","author":"Diesch","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0071","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/leu.2013.269","article-title":"Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms","volume":"28","author":"Traina","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0072","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis","volume":"160","author":"Kulasekararaj","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0073","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2404145","article-title":"High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration","volume":"20","author":"Paulsson","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0074","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/leu.2010.213","article-title":"IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia","volume":"24","author":"Caramazza","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0076","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.12710","article-title":"Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact","volume":"164","author":"Bacher","year":"2014","journal-title":"British journal of haematology"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0077","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1182\/blood-2010-11-314393","article-title":"SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes","volume":"117","author":"Afable","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0078","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjh.12603","article-title":"Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes","volume":"164","author":"Babushok","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2015.10.002","article-title":"Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia","volume":"209","author":"Betensky","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0081","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debre","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0082","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0083","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0084","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0085","first-page":"1","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS","volume":"36","author":"Valent","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0086","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0087","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11899-012-0140-3","article-title":"Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors","volume":"7","author":"Steensma","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0088","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0089","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0090","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1182\/blood-2015-08-663237","article-title":"Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression","volume":"126","author":"Cargo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0091","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.exphem.2008.10.012","article-title":"Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500\u202fK SNP arrays identifies significant regions of deletion and uniparental disomy","volume":"37","author":"Nowak","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0092","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/erm.12.18","article-title":"Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes","volume":"12","author":"Jacoby","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0093","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2009-11-203182","article-title":"SNP array analysis in hematologic malignancies: avoiding false discoveries","volume":"115","author":"Heinrichs","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0094","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-06-3597","article-title":"Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays","volume":"67","author":"Jacobs","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0095","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1158\/0008-5472.CAN-05-2486","article-title":"Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays","volume":"65","author":"Lips","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0096","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/humu.20220","article-title":"Whole genome SNP arrays using DNA derived from formalin-fixed, paraffin-embedded ovarian tumor tissue","volume":"26","author":"Thompson","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0097","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmr.2193","article-title":"Early adhesion of human mesenchymal stem cells on TiO(2) surfaces studied by single-cell force spectroscopy measurements","volume":"25","author":"Bertoncini","year":"2012","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0098","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-8794-2-8","article-title":"High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays","volume":"2","author":"Wang","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0099","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1101\/gr.5686107","article-title":"High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays","volume":"17","author":"Oosting","year":"2007","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2407-7-43","article-title":"Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material","volume":"7","author":"Joosse","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygeno.2005.09.019","article-title":"Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA","volume":"87","author":"Little","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13039-015-0136-5","article-title":"Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome","volume":"8","author":"Stevens-Kroef","year":"2015","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0103","doi-asserted-by":"crossref","first-page":"18845","DOI":"10.18632\/oncotarget.4586","article-title":"Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?","volume":"6","author":"Peterson","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0104","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cancergen.2013.09.001","article-title":"The advantage of using SNP array in clinical testing for hematological malignancies\u2013a comparative study of three genetic testing methods","volume":"206","author":"Xu","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/gcc.22350","article-title":"Guidelines for genomic array analysis in acquired haematological neoplastic disorders","volume":"55","author":"Schoumans","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0106","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/gcc.22455","article-title":"Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial","volume":"56","author":"Stevens-Kroef","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0107","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.leukres.2010.07.004","article-title":"Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML","volume":"34","author":"Barresi","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0108","series-title":"Detection of cnLOH as a Sole Abnormality in the Diagnosis of Myelodysplastic Syndrome","author":"Gronseth","year":"2016"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2011.01710.x","article-title":"Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations","volume":"88","author":"Larsson","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.prp.2014.02.006","article-title":"Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis","volume":"210","author":"Kunze","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0111","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3324\/haematol.2009.013623","article-title":"High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations","volume":"95","author":"Stegelmann","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0112","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/gcc.20748","article-title":"Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis","volume":"49","author":"Huh","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0113","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000343420","article-title":"Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality","volume":"129","author":"Hahm","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bjhh.2014.09.011","article-title":"Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes","volume":"37","author":"Noronha","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.12710","article-title":"Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact","volume":"164","author":"Bacher","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ajcp\/aqw077","article-title":"Bone marrow conventional karyotyping and fluorescence in situ hybridization: defining an effective utilization strategy for evaluation of myelodysplastic syndromes","volume":"146","author":"He","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0117","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.leukres.2011.10.014","article-title":"The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure","volume":"36","author":"Jiang","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.07.003_bib0118","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1309\/AJCPW10YBRMWSWYE","article-title":"Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and\/or acute myeloid leukemia: a prospective analysis of 433 cases","volume":"135","author":"Coleman","year":"2011","journal-title":"Am J Clin Pathol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:44:38Z","timestamp":1761896678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":118,"alternative-id":["S2210776218300607"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.07.003","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic\/myeloproliferative and myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}